Refine results by

Publication dates

All premium reports for Pharmaceutical Industry Analysis and Statistics (since 2008 - p4)

 

91-120 of 6 467 Premium Reports from 56 Publishers

Generics in Europe

Generics in Europe

  • $ 250
  • September 2009

Datamonitor's Generics in Europe industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...

Industries : Generic Drug

Generics in France

Generics in France

  • $ 250
  • September 2009

Datamonitor's Generics in France industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...

Industries : Generic Drug

Generics in Germany

Generics in Germany

  • $ 250
  • September 2009

Datamonitor's Generics in Germany industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies an ...

Industries : Generic Drug

Generics in Italy

Generics in Italy

  • $ 250
  • September 2009

Datamonitor's Generics in Italy industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...

Industries : Generic Drug

Generics in Japan

Generics in Japan

  • $ 250
  • September 2009

Datamonitor's Generics in Japan industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...

Industries : Generic Drug

Generics in Spain

Generics in Spain

  • $ 250
  • September 2009

Datamonitor's Generics in Spain industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...

Industries : Generic Drug

Generics in the Netherlands

Generics in the Netherlands

  • $ 250
  • September 2009

Datamonitor's Generics in the Netherlands industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading comp ...

Industries : Generic Drug

Generics in the United Kingdom

Generics in the United Kingdom

  • $ 250
  • September 2009

Datamonitor's Generics in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading c ...

Industries : Generic Drug

Generics in the United States

Generics in the United States

  • $ 250
  • September 2009

Datamonitor's Generics in the United States industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading co ...

Industries : Generic Drug

Vietnam Pharmaceuticals and Healthcare Report Q4 2009

Vietnam Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

BMI?s drug forecast for Vietnam has been affected in recent months by negative macroeconomic factors.Vietnam, like many of Asia?s export-focused manufacturing economies, is vulnerable to a downturn inWestern markets in which much of its output is consumed. This has a knock on effect on employment an ...

Industries : Healthcare, Pharmaceutical

Italy Pharmaceuticals and Healthcare Report Q4 2009

Italy Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

Despite the Italian pharmaceuticals market being the sixth largest globally, its potential for expansionlooks to be limited based on recent trends, including the contraction of the prescription market. The totalmarket contracted in both 2007 and 2008, when it reached EUR18.87bn (US$27.75bn). The ma ...

Industries : Healthcare, Pharmaceutical

Netherlands Pharmaceuticals and Healthcare Report Q4 2009

Netherlands Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

BMI calculates the Netherlands?s pharmaceutical expenditure to have been EUR5.8bn (US$8.5bn) in2008. By 2013, we expect the total amount spent on prescription and OTC medicines to have reachedEUR6.6bn, equating to a compound annual growth rate (CAGR) of 2.7%.Looking forward, BMI?s new 10-year foreca ...

Industries : Healthcare, Pharmaceutical

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2009

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

Puerto Rico?s pharmaceutical market is showing sizeable growth in nominal terms (11.6% year-on-year(y-o-y) in 2009), but high inflation in the economy will erode many of these gains. BMI expects thePuerto Rican drug market to increase from US$2.9bn in 2008 to US$4.086bn by 2013, representing acompou ...

Industries : Healthcare, Pharmaceutical

Israel Pharmaceuticals and Healthcare Report Q4 2009

Israel Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

In BMI?s Business Environment Rankings (BER) for Q409, Israel once again slipped down the table ofthe 17 Middle East and African (MEA) markets surveyed, now ranking 11th. Despite the country?swealthy and urbanised population, its regulatory environment, falling state contribution to healthcare andpo ...

Industries : Healthcare, Pharmaceutical

Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2009

Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

In BMI?s updated Business Environment Rankings (BER), Saudi Arabia is ranked second, out of the 17Middle East and African (MEA) markets surveyed. The country?s score is propped up by its sizeable andwealthy population as well as a steady forecast annual growth of its drug expenditure. Over the forec ...

Industries : Healthcare, Pharmaceutical

Booming Clinical Trials Market in India - September 09 Reedition

Booming Clinical Trials Market in India - September 09 Reedition

  • $ 1 050
  • September 2009
  • 50 pages

The clinical trial market in India looks very lucrative. The country promises to be one of the hottest destinations for conducting global clinical trials, owing to a huge patient pool representing both chronic and infectious diseases, easy recruitment of patients, and high cost savings. Moreover, th ...

Industries : Pharmaceutical | Countries : India

Excipients in Pharmaceuticals - 2009 Edition

Excipients in Pharmaceuticals - 2009 Edition

  • $ 4 850
  • September 2009

THIS REPORT WILL:Provide a detailed analysis of the excipients market today and a forecast of what the market will look like in 5 yearsOffer information on inert ingredients, the types of technologies used to make them, their uses, and regulatory influences Highlight excipients by chemical compounds ...

Industries : Pharmaceutical

Hong Kong Pharmaceuticals and Healthcare Report Q4 2009

Hong Kong Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

According to BMI?s Asia Pacific Pharmaceuticals & Healthcare Business Environment Ranking table forQ409, Hong Kong?s pharmaceutical market slipped from being the fifth-most attractive in the region to ajoint sixth. Globally, Hong Kong places joint 25th out of the 71 countries surveyed by BMI. Althou ...

Industries : Healthcare, Pharmaceutical

Philippines Pharmaceuticals and Healthcare Report Q4 2009

Philippines Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

The Q409 update of BMI?s Philippines Pharmaceuticals & Healthcare report contains for the first time a10-year forecast for medicine expenditure. The US$2.61bn market is forecast to experience slight growthof 1.8% in 2009. This is mainly due to local currency depreciation, but also a deterioratingmac ...

Industries : Healthcare, Pharmaceutical

Belgium Pharmaceuticals and Healthcare Report Q4 2009

Belgium Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

In BMI?s Business Environment Rankings (BER) for Q409, Belgium rose by one place to 7th position inthe regional matrix, out of the 9 countries surveyed in Western Europe. While its advanced status, ageingpopulation and high per-capita income should support market development going forwards, annualg ...

Industries : Healthcare, Pharmaceutical

Bulgaria Pharmaceuticals and Healthcare Report Q4 2009

Bulgaria Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

Bulgaria?s pharmaceutical market has transformed from the low-value, low-growth market of just a fewyears ago to one of the fastest-growing in Central and Eastern Europe (CEE). EU accession has helpedboost sales of higher value products, while regulatory developments have added greater transparency ...

Industries : Healthcare, Pharmaceutical

Germany Pharmaceuticals and Healthcare Report Q4 2009

Germany Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

BMI calculates Germany?s pharmaceutical expenditure to have been EUR37.3bn (US$55.0bn) in 2008.By 2013, we expect the total amount spent on prescription and OTC medicines to have reached a value ofEUR41.7bn, equating to a compound annual growth rate (CAGR) of 3.7% in local currency terms.However, d ...

Industries : Healthcare, Pharmaceutical

Qatar Pharmaceuticals and Healthcare Report Q4 2009

Qatar Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

Qatar is now ranked third out of 17 countries in the Middle East and Africa (MEA) region in BMI?s Q409Business Environment Rankings (BER), slipping from second in the previous quarter. While Qatar offersa favourable market and country structure, including a predictable operating environment and a so ...

Industries : Healthcare, Pharmaceutical

Iran Pharmaceuticals and Healthcare Report Q4 2009

Iran Pharmaceuticals and Healthcare Report Q4 2009

  • $ 495
  • September 2009

We expect the total drug market to increase in value from US$2.17bn in 2008 to US$3.21bn by 2013,representing a compound annual growth rate (CAGR) of 8.2% in US dollar terms. Pharmaceuticalspending will comprise 0.65% of GDP, and US$41.60 per capita spending by 2013. We believe thatgrowth will be d ...

Industries : Healthcare, Pharmaceutical

Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)

Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)

  • $ 4 650
  • September 2009

Report DescriptionThe global market for neurostimulation products is expected to be worth $3.6 billion in 2009, growing at a CAGR of 22.7%, driven by the multiple treatment applications of neurostimulation products, and the emergence of venture capital in the industry.Neurostimulation is used for th ...

Industries : Therapy

Physical Therapists in the US- 2009 Edition

Physical Therapists in the US- 2009 Edition

  • $ 715
  • September 2009

INDUSTRY MARKET RESEARCH REPORTThis is the replacement for March 2009 edition of Physical Therapists in the US report.Industry Market Research SynopsisThis Industry Market Research report provides a detailed analysis of the Physical Therapists in the US industry, including key growth trends, statis ...

Industries : Therapy

Middle East and Africa Pharma Sector Forecast to 2012

Middle East and Africa Pharma Sector Forecast to 2012

  • $ 1 050
  • September 2009

The Middle East and Africa pharmaceutical industry is entering a new era, with the development of infrastructure system and rapidly changing regulations. The industry is blessed with several advantages like high prevalence of diseases, huge population base and many more, reflecting bight prospects o ...

Industries : Pharmaceutical

Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity

Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity

  • $ 3 835
  • September 2009

Parallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following legislation allowing drugs to be imported into the US from Canada. However, counterfeit drug ...

Industries : Pharmaceutical

The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities

The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities

  • $ 3 835
  • September 2009

The Middle East pharmaceutical market is diverse, with a significant presence of leading global players alongside domestic pharmaceutical companies such as Ibrahim, Bilim and Deva. The market dynamics are further shaped by the presence of several leading suppliers of branded generics and APIs (activ ...

Industries : Pharmaceutical

Analgesics in Mexico

Analgesics in Mexico

  • $ 844
  • September 2009

Euromonitor International's Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading ...

Industries : Generic Drug

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.